Silver Nanoparticles for Drug Delivery
- 1st Edition - November 29, 2023
- Editor: Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 5 3 4 3 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 5 3 4 4 - 0
Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regula… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote- Delivers the complete journey of silver nanoparticles in drug delivery, from the fundamentals to the most recent applications
- Provides an in-depth novel application of silver nanoparticles in biological milieu
- Presents a vital source for researchers in silver nanoparticles based targeted drug delivery, nanomedicine and engineering
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- About the editor
- Preface
- Acknowledgments
- Chapter 1. History, introduction, and physicochemical properties of silver nanoparticles
- Abstract
- 1.1 Introduction
- 1.2 Ancient history silver
- 1.3 Discovery of silver nanoparticles
- 1.4 Physicochemical properties of silver nanoparticles
- 1.5 General applications of silver nanoparticles
- 1.6 Silver nanoparticles with biomedical applications
- 1.7 Conclusion
- References
- Chapter 2. Synthesis methods and characterization parameters of silver nanoparticles
- Abstract
- 2.1 Introduction
- 2.2 Synthesis methods of AgNPs
- 2.3 Characterization parameters of AgNPs
- 2.4 Conclusion
- Conflicts of interest
- References
- Chapter 3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery
- Abstract
- 3.1 Introduction
- 3.2 Experimental and applications
- 3.3 Conclusion
- References
- Chapter 4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery
- Abstract
- 4.1 Introduction
- 4.2 Various methods of silver nanoparticles synthesis
- 4.3 Silver nanoparticles antimicrobial therapeutics
- 4.4 Mechanisms of action of antimicrobial agents
- 4.5 Antiviral ability of silver nanoparticles
- 4.6 The mechanisms of antiviral action of silver NPs
- 4.7 Anti-inflammatory activity
- 4.8 AgNPs treat wounds infections
- 4.9 Anticancer drugs
- 4.10 Alzheimer’s disease
- 4.11 Future applications
- References
- Chapter 5. Silver nanoparticles for cancer diagnosis and treatment of cancer
- Abstract
- 5.1 Introduction
- 5.2 Mechanism of action of anticancer property
- 5.3 Silver nanoparticles in cancer diagnosis
- 5.4 Silver nanoparticles in cancer therapy
- 5.5 Silver nanoparticles: challenges and limitations in cancer therapy
- 5.6 Future perspective
- 5.7 Conclusion
- References
- Chapter 6. Silver nanoparticles to enhance photodynamic action of photosensitizers
- Abstract
- 6.1 Introduction
- 6.2 Fundamentals of the photodynamic effect
- 6.3 AgNPs in the photodynamic action
- 6.4 Applications of AgNPs in photodynamic treatment
- 6.5 Final remarks
- Acknowledgments
- References
- Chapter 7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm
- Abstract
- 7.1 Introduction
- 7.2 Key concepts
- 7.3 Bacterial activity of AgNPs
- 7.4 Perspectives
- Acknowledgments
- References
- Chapter 8. Silver nanoparticles in wound therapy and tissue regeneration
- Abstract
- 8.1 Introduction
- 8.2 Different types of embedded silver nanoparticles
- 8.3 Properties of silver nanoparticles that fasten wound healing
- 8.4 The mechanism of wound healing and tissue regeneration
- 8.5 Case studies of silver nanoparticles in wound therapy and tissue regeneration
- 8.6 Toxicity associated with silver nanoparticles
- 8.7 Conclusion and future perspective
- Acknowledgements
- References
- Chapter 9. Silver nanoparticles for drug delivery in inflammatory bowel disease
- Abstract
- Abbreviations
- 9.1 Introduction
- 9.2 Silver nanoparticles: characterization and synthesis
- 9.3 Biological properties of silver nanoparticles
- 9.4 Silver nanoparticle toxicity testing
- 9.5 Silver nanoparticles as potential drugs in IBD
- 9.6 IBD and colon-target drug delivery system
- 9.7 Conclusions
- Acknowledgements
- Authors’ contributions
- Author disclosures
- References
- Chapter 10. Silver nanoparticles for the management of neurological diseases
- Abstract
- Abbreviations
- 10.1 Introduction
- 10.2 Biomedical applications of AgNPs in CNS diseases
- 10.3 Knowledge gaps and challenges for the CNS clinical translation of AgNPs
- 10.4 Conclusions and future perspectives
- Acknowledgments
- References
- Chapter 11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements
- Abstract
- 11.1 Introduction
- 11.2 Synthesis of silver nanoparticles
- 11.3 Chemical synthesis of silver nanoparticles
- 11.4 Physical synthesis of silver nanoparticles
- 11.5 Biological synthesis of silver nanoparticles
- 11.6 Bacteria-derived synthesis of silver nanoparticles
- 11.7 Fungi-derived synthesis of silver nanoparticles
- 11.8 Plant-derived synthesis of silver nanoparticles
- 11.9 Phytochemicals-derived synthesis of silver nanoparticles
- 11.10 Silver nanoparticles and their antidiabetic agents
- 11.11 SNP mechanism of action in diabetic management
- 11.12 Silver nanoparticles and their diabetic wound healing
- 11.13 Conclusions
- Acknowledgment
- Conflict of interest
- References
- Chapter 12. Silver nanoparticles in dentistry
- Abstract
- 12.1 Introduction
- 12.2 Antimicrobial properties of silver nanoparticles
- 12.3 Silver nanoparticles in dentistry
- 12.4 Conclusion and future prospects
- References
- Chapter 13. Silver nanoparticles and their role in the treatment of endodontic infections
- Abstract
- 13.1 Introduction
- 13.2 Silver nanoparticles in dentistry
- Acknowledgment
- References
- Chapter 14. Silver nanoparticles for treatment of COVID-19 and other viral diseases
- Abstract
- 14.1 Introduction
- 14.2 Silver nanoparticles for diagnosis of COVID-19 and other viral diseases
- 14.3 Nanoparticles for vaccine development against COVID-19 and other viral diseases
- 14.4 Mechanisms of antiviral activities of silver nanoparticles
- 14.5 Silver nanoparticles for treatment of COVID-19
- 14.6 Silver nanoparticles for treatment of other viral diseases
- 14.7 Silver nanoparticles in clinical trials for COVID-19 and other viral/microbial diseases
- 14.8 Limitations of silver nanoparticles for treatment of COVID-19 and other viral diseases
- 14.9 Conclusions
- Acknowledgment
- References
- Chapter 15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles
- Abstract
- 15.1 Introduction
- 15.2 AgNPs and biological toxicity
- 15.3 Environmental and safety issues of AgNPs
- 15.4 Conclusion
- References
- Chapter 16. Silver nanoparticle–induced ecotoxicity
- Abstract
- 16.1 Introduction
- 16.2 Silver nanoparticles’ (AgNPs) discharge into environments and estimated concentrations
- 16.3 Intrinsic properties and transformations influencing AgNP ecotoxicity
- 16.4 Main AgNP ecotoxicological effects on biota
- 16.5 Concluding remarks and gaps of knowledge
- Acknowledgments
- Author contributions
- Declaration of competing interest
- References
- Chapter 17. Clinical translation of silver nanoparticles into the market
- Abstract
- 17.1 Introduction
- 17.2 Overview on the market status and clinical profile of AgNPs
- 17.3 Challenges hampering the clinical translation of AgNPs
- 17.4 Approaches enabling the clinical translation of AgNPs
- 17.5 Competing technologies to AgNPs
- 17.6 Concluding remarks and future perspectives
- References
- Chapter 18. Conclusion and future prospective of silver nanoparticles
- Abstract
- 18.1 Introduction
- 18.2 Synthesis of silver nanoparticles and its biological effects
- 18.3 Physicochemical properties of silver nanoparticles
- 18.4 Different applications of silver nanoparticles
- 18.5 Toxicity and environmental risk of silver nanoparticles
- 18.6 Summary and outlook
- Acknowledgements
- References
- Index
- No. of pages: 550
- Language: English
- Edition: 1
- Published: November 29, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780443153433
- eBook ISBN: 9780443153440
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.